Fogarty International Center Global Health Matters
 
  APRIL 2004
Skip repetitive navigation
 

In this issue:

   Senator Jack Reed Hosts FIC Roundtable
   Message From the Director
   World AIDS Foundation (WAF) closes its doors
   New Visiting Fellows group formed
   FIC helps Israeli and Palestinian scientists collaborate
   Career Paths for Women in the Health Sciences
   Progress partnerships for students, young scientists
   Middle Eastern Research Opportunities for Women
   Articles in this issue
  Printer-Friendly PDF
(167KB)
  FIC Home Page

 

 

Global Health Matters > World AIDS Foundation's Work Draws to a Close

World AIDS Foundation's Work Draws to a Close

It was a bittersweet moment when the World AIDS Foundation (WAF) celebrated its accomplishments at a scientific symposium convened last July at the Institut Pasteur in Paris. The Foundation was created in 1988 to help combat and prevent HIV/AIDS in developing countries through research and education. Its funds were derived solely from royalties on the sale of blood tests devised to detect antibodies to HIV, the virus that causes AIDS. The patent on these tests expires in April 2004, ending royalty payments and, as a consequence, the granting of new WAF awards.

"WAF has had an enormous impact," said Kenneth Bridbord, M.D., Director of FIC's Division of International Training and Research, who has been involved with WAF since its inception. "It carved out a unique area in HIV/AIDS funding by focusing on training and by building public health capacity in developing countries. It is a tribute to all involved that they recognized quite early in the epidemic that HIV/AIDS had the potential to affect developing nations in a devastating way," explained Dr. Bridbord.

WAF was established following an agreement between Presidents Jacques Chirac of France and Ronald Reagan of the United States. The declared codiscoverers of the cause of AIDS, Robert Gallo, M.D., and Luc Montagnier, M.D., readily agreed that 25% of royalties from the diagnostic test designed to detect its presence should be used to help combat the growing pandemic. Dr. Gallo, who directs the Institute of Human Virology at the University of Maryland, said, "The World AIDS Foundation was the first of its kind. We are all proud to be a part of an organization whose sole goal was unselfishly [helping] developing nations. It is a model not only for AIDS but for how things can be done in many walks of life and all aspects of medicine, and that is its legacy."

In its 15 years of operation, WAF granted $25 million in awards to further the understanding of AIDS and stem its spread. It funded more than 300 projects that have helped 80 developing countries in Africa, Latin America and the Caribbean, the Far East and the Pacific, and Eastern Europe, Russia, and the Newly Independent States of the former Soviet Union. Most awards were for 2 years, and the maximum for any single award was $150,000. Nearly half the grants involved some form of collaboration with U.S. scientists to support work in developing countries. Increasingly, WAF was making awards directly to developing countries.

The largest number of grants awarded went to scientists from China, India, Vietnam, Brazil, Nigeria, Peru, Ukraine, Cameroon, Thailand, and Uganda, in that order. Although total funding was not nearly as substantial as amounts currently offered by the Gates Foundation or the Global Fund to fight AIDS, TB, and malaria, WAF supported efforts at a relatively early stage in the HIV/AIDS epidemic and focused on areas not covered by these and other groups.

Examples of funded projects included the following: WAF facilitated a confidential HIV/AIDS counseling and testing center in Tbilisi, Georgia, and a program to prevent sexually transmitted diseases (STDs) and AIDS in mining areas of Ghana. It funded programs for safe blood transfer in Peru and AIDS prevention through literacy and education in Malawi. In addition, it provided training for trainers and peer educators for HIV/AIDS prevention in Turkey as well as funds for researching a reagent in India for detecting anti-HIV antibodies in a drop of whole blood.

Dr. Bridbord lauds the WAF grantees, calling them "the real heroes" out front in the fight against AIDS. One hero he cites is Jean Pape, M.D., a professor at Cornell University and the State University in Haiti. Dr. Pape and colleagues, with the help of a WAF award at a very early phase in Haiti's response to HIV/AIDS, enhanced the activities of the Haitian Study Group on Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), a research center founded in 1982 by Haitian health professionals. Much of what is known about the clinical presentation, epidemiology, and trans-mission of AIDS in Haiti comes from studies carried out by GHESKIO, which today receives walk-in and referral patients from throughout Haiti and screens them for HIV, STDs, and tuberculosis. This and other WAF awards helped Haitian health authorities establish their response to the growing AIDS threat in their country.

Apart from providing financial support, WAF awards played a crucial role in helping educate developing-world scientists and governments on how to compete successfully in international grant systems. WAF awards were among the first that developing countries received from a research foundation on a competitive basis. It was a chance for health professionals from developing countries, who had good ideas but not much experience with grants, to present their ideas for consideration and have a realistic chance of being funded.

FIC, first representing NIH and subsequently the U.S. Department of Health and Human Services, played an integral role in WAF programs from the beginning. Moreover, WAF projects spurred more than a dozen FIC International HIV/AIDS and tuberculosis training and research capacity-building programs in countries such as Poland, Mongolia, Peru, and Rwanda. WAF programs also enhanced NIH-supported HIV/AIDS programs in India, Russia, and South Africa and Centers for Disease Control and Prevention-supported HIV/AIDS activities in the Congo, Côte D'Ivoire, and Thailand.

WAF will continue to exist to support projects that have already been awarded. It is anticipated that these projects will continue for at least 2 more years. Funded projects have encouraged a cadre of qualified, independent researchers in the developing world and have helped prepare them to seek new sources of funding from major international funding organizations. "It is our hope," said Dr. Bridbord, "that the goals of the WAF will continue to be met, thanks to the efforts of all the talented and dedicated people who have been associated with this project over the years."

 

 

^ TOP OF PAGE